“Integrated Efficacy of FMX101 4% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Acne Vulgaris: Analyses of Efficacy in Clinically Relevant Subgroups of Patients”, J of Skin, vol. 4, no. 6, p. s89, Oct. 2020, doi: 10.25251/skin.4.supp.89.